Cerus (CERS) Asset Utilization Ratio (2011 - 2026)

Cerus (CERS) posted Asset Utilization Ratio of 1.16 for Q2 2026, up 6.02% sequentially from 1.1 in Q1 2026, and up 14.45% YoY from 1.02 in Q2 2025.

Cerus (CERS) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Cerus has reported Asset Utilization Ratio for 16 years, with the latest figure at 1.16 in Q2 2026.

Quarterly Asset Utilization Ratio rose 14.45% year-over-year to 1.16 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1.16 (up 14.45% YoY) and the FY2025 annual result came in at 1.11, up 9.51% from the prior year.
Asset Utilization Ratio advanced to 1.16 in Q2 2026 per CERS's latest filing, from 1.1 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 1.16 in Q2 2026 and troughed at 0.76 in Q1 2022.
A 5-year average of 0.97 and a median of 1.01 in 2024 frame the typical range for Asset Utilization Ratio.
The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio surged 43.7% in 2022, then fell 6.67% in 2025.
Over 5 years, Asset Utilization Ratio stood at 0.87 in 2022, then advanced by 6.54% to 0.93 in 2023, then climbed by 11.4% to 1.03 in 2024, then climbed by 3.75% to 1.07 in 2025, then advanced by 8.82% to 1.16 in 2026.
According to Business Quant data, Asset Utilization Ratio over the past three periods registered 1.16, 1.1, and 1.07 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.42
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.55
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.39
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.47
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.48
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	0.76
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.57
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.80
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.56
10	Cerus	560.58 Mn	504.32 Mn	29.53 Mn	1.16

Download Data